Specification - Extended HL7 CDA® R2 IG: C-CDA Templates for Clinical Notes DSTU Release 2.1 - US Realm
Document Description extended per extended per TSC tracker 12437, again with 14128 and jira.hl7.org/browse/TSC-38
Existing WordingVolume 1 3.5 Narrative Reference The C-CDA R1.1 release recommended that clinical statements include a link between the narrative (section.text) and coded clinical data (entry). Rather than repeat these constraints in every applicable entry, SDWG agreed in R2.0 to apply the following constraint to all entry templates, unless explicitly prohibited. SHOULD contain zero or one [0..1] text (CONF:XXXX). a. The text, if present, SHOULD contain zero or one [0..1] reference/@value (CONF: XXXX). i. This reference/@value SHALL begin with a '#' and SHALL point to its corresponding narrative (using the approach defined in CDA R2.0, section 4.3.5.1) (CONF: XXXX). MAY contain zero or one [0..1] originalText (CONF:XXXX). a. The originalText, if present, SHOULD contain zero or one [0..1] reference/@value (CONF:XXXX). i. This reference/@value SHALL begin with a '#' and SHALL point to its corresponding narrative (using the approach defined in CDA R2.0, section 4.3.5.1) (CONF:XXXX).
Proposed WordingThese conformance constraints in Volume 1 need to be populated with a Conformance Statement identifier that is a unique id for this IG.